Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-12-12
1990-02-27
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514460, 514824, 549292, A61K 31365, C07D30930
Patent
active
049046926
ABSTRACT:
Disclosed are novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors useful as antihypercholesterolemic agents represented by the formula ##STR1## and the corresponding ring-opened hydroxy acids derived therefrom and pharmaceutically acceptable salts thereof.
Pharmaceutical compositions containing said compounds and method of inhibiting the biosynthesis of cholesterol therewith are also disclosed.
REFERENCES:
patent: 4282155 (1981-08-01), Smith et al.
patent: 4375475 (1983-03-01), Willard et al.
patent: 4567289 (1986-01-01), Willard et al.
patent: 4611067 (1986-09-01), Volante et al.
patent: 4622338 (1986-11-01), Baron et al.
patent: 4668699 (1987-05-01), Hoffman et al.
patent: 4681893 (1987-07-01), Roth
Bruno Josehp G.
Kuhla Donald E.
Neuenschwander Kent W.
Regan John R.
Balogh Imre (Jim)
Nicholson James A.
Raymond Richard L.
Rorer Pharmaceutical Corporation
Russell Mark W.
LandOfFree
Novel HMG-CoA reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel HMG-CoA reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel HMG-CoA reductase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-174586